3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Dengue: new trials by email Literature Review of Dengue trials Research Report on Dengue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of JNJ-64281802 for the Prevention of Dengue Infection JNJ-64281802, Placebo - Dengue | Phase 2 | Terminated | Janssen Research & Development, LLC | 1595 | 2023-02-22 | 2025-07-31 |
| Study of AT-752 in Patients With Dengue Infection AT-752, Placebo - Dengue Fever | Phase 2 | Terminated | Atea Pharmaceuticals, Inc. | 21 | 2022-04-29 | 2024-03-05 |
| A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever JNJ-64281802, Placebo - Dengue | Phase 2 | Terminated | Janssen Research & Development, LLC | 5 | 2022-01-24 | 2024-03-01 |
Hemorrhagic Fevers, Viral (1) · Infections (1) · Vector Borne Diseases (1) · Virus Diseases (1)
Arbovirus Infections (3) · Flaviviridae Infections (3) · Flavivirus Infections (3) · Mosquito-Borne Diseases (3) · RNA Virus Infections (3) · Hemorrhagic Fevers, Viral (2) · Infections (2) · Vector Borne Diseases (2) · Virus Diseases (2)
AT-752 (1)
Janssen Research & Development, LLC (2) · Atea Pharmaceuticals, Inc. (1)
Brazil (2) · Colombia (2) · Malaysia (2) · Peru (2) · Philippines (2) · Thailand (2) · Ecuador (1) · India (1) · Mexico (1) · Panama (1) · Puerto Rico (1) · Singapore (1) · Taiwan (1) · Vietnam (1)